Abstract:Epidemiological studies have identified that the risk of cardiovascular events increases due to the decreased levels of high density lipoprotein-cholesterol and the elevated levels of low density lipoprotein-cholesterol. Herein, we report a novel series of N,N-3-phenyl-3-benzylaminopropionanilide derivatives, which were identified as potent cholesteryl ester transfer protein (CETP) inhibitor. The initial lead compound L10 (IC50 8.06μM) was found by pharmacophore-based virtual screening (Dong-Mei Zhao et al., Chin. Chem. Lett. 2014, 25, 299). After systematic structure variation and biological testing against CETP, two different series were identified as scaffolds for potent CETP inhibitors. One is N,N-3-phenyl-3-benzylaminopropanamide derivatives, which were investigated in our previous paper (Bioorg. Med. Chem. 2015, doi: http://dx.doi.org/10.1016/j.bmc.2015.12.010). The most potent compound HL16 in that series has the IC50 of 0.69μM. The other series is N,N-3-phenyl-3-benzylaminopropionanilide derivatives, which was investigated in current study. Further optimization of the structure–activity relationship (SAR) resulted in H16 (IC50 0.15μM), which was discovered as a potent CETP inhibitor in vitro by BODIPY-CE fluorescence assay. In addition, the results of pharmacodynamics studies showed that H16 exhibited both favorable HDL-C enhancement and LDL-C reduction in vivo by hamster. It also has an excellent stability in rat liver microsomal.

Β-C-glycosiduronic Acids and Β-C-glycosyl Compounds: New PTP1B Inhibitors

Synthesis of Triazole-Linked Beta-C-glycosyl Dimers As Inhibitors of PTP1B.

Preparation of triazole-linked glycosylated α-ketocarboxylic acid derivatives as new PTP1B inhibitors.

Triazole-Linked Benzylated Glucosyl, Galactosyl, and Mannosyl Monomers and Dimers As Novel Sugar Scaffold-Based Ptp1b Inhibitors

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

Synthesis of Triazole-Linked Amino Acid-Aryl C -Glycoside Hybrids Via Click Chemistry As Novel PTP1B Inhibitors

Synthesis of (Glycopyranosyl-Triazolyl)-purines and Their Inhibitory Activities Against Protein Tyrosine Phosphatase 1B (PTP1B)

Discovery of Core-Structurally Novel PTP1B Inhibitors with Specific Selectivity Containing Oxindole-Fused Spirotetrahydrofurochroman by One-Pot Reaction.

In the Search of Glycogen Phosphorylase Inhibitors: Synthesis of C-D-Glycopyranosylbenzo(hydro)quinones – Inhibition of and Binding to Glycogen Phosphorylase in the Crystal

Synthesis of 2-ethoxycarbonylthieno[2,3- b ]quinolines in biomass-derived solvent γ-valerolactone and their biological evaluation against protein tyrosine phosphatase 1B

Identification of Lipid-Like Salicylic Acid-Based Derivatives As Potent and Membrane-Permeable PTP1B Inhibitors

Studies on inhibiting effects on PTP1B of two butanoic acid glycosides from Anoectochilus roxburghii

Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity.

Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity

Synthesis and biological evaluation of oleanolic acid derivatives as PTP1B inhibitors.

Y-shaped Bis-Arylethenesulfonic Acid Esters: Potential Potent and Membrane Permeable Protein Tyrosine Phosphatase 1B Inhibitors.

Microwave-assisted Construction of Triazole-Linked Amino Acid–glucoside Conjugates As Novel PTP1B Inhibitors

Design, synthesis, biological evaluation and molecular dynamics simulation studies of imidazolidine-2,4-dione derivatives as novel PTP1B inhibitors

Synthesis and Biological Evaluation of Geniposide Derivatives As Potent and Selective PTPlB Inhibitors.

Discovery and Evaluation of the Hybrid of Bromophenol and Saccharide As Potent and Selective Protein Tyrosine Phosphatase 1B Inhibitors

Discovery of Bisindole As A Novel Scaffold for Protein Tyrosine Phosphatase 1b Inhibitors